Project description
International study to validate AI for the prediction of treatment response in breast cancer
Radiomics is a quantitative approach to medical imaging that extracts information not accessible through traditional visual inspection of generated images, particularly in oncology. The aim of the EU-funded RadioVal project is to evaluate the potential of radiomics to predict response to neoadjuvant chemotherapy in breast cancer patients, using AI. The project will leverage large imaging repositories and results generated by previous EU-funded projects. Furthermore, RadioVal will implement a multi-faceted evaluation of radiomics AI tools in eight hospitals across Europe and beyond, to test their technical robustness, algorithmic fairness, as well as usability and acceptance in clinical setting. The results are expected to increased trust in AI-driven clinical decision-making, and reduce over-treatment and improve clinical outcome for breast cancer patients.
Fields of science
Programme(s)
Funding Scheme
HORIZON-AG - HORIZON Action Grant Budget-BasedCoordinator
08007 Barcelona
Spain
See on map
Participants (15)
6200 MD Maastricht
See on map
46021 Valencia
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
70013 Irakleio
See on map
47822 Santarcangelo Di Romagna
See on map
3030-163 Coimbra
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
00210 Helsinki
See on map
46026 Valencia
See on map
17177 Stockholm
See on map
80210 Gdansk
See on map
10 000 Zagreb
See on map
1090 Wien
See on map
06800 Cankaya Ankara
See on map
C1426NZ Buenos Aires
See on map
11566 Abassyia Cairo
See on map
1010 Wien
See on map